{"id":"W4417464386","doi":"10.51731/cjht.2025.1309","title":"Darolutamide (Nubeqa)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Enzalutamide; Agency (philosophy); Drug; Drug approval","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002912674,0.0002601713,0.000549563,0.00135446,0.0007114511,0.001450115,0.0008985414,0.0007930766,0.01455998],"category_scores_gemma":[0.007615006,0.0001456726,0.0005655668,0.001260419,0.0004416079,0.0007115612,0.0009039789,0.001434631,0.004003847],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.006059029,"about_ca_system_score_gemma":0.01181008,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.03960303,"about_ca_topic_score_gemma":0.1219615,"domain_scores_codex":[0.9979267,0.0004733957,0.0001550485,0.0001767227,0.001069969,0.0001981894],"domain_scores_gemma":[0.9956697,0.000450758,0.0004802359,0.0002064388,0.002520404,0.0006724434],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00103801,0.0001831173,0.002915423,0.001068589,0.00008687264,0.0002132863,0.00008620974,0.0002140284,0.00257138,0.006675702,0.2103234,0.774624],"study_design_scores_gemma":[0.0003347895,0.0002187146,0.003479988,0.0004212275,0.00005374773,0.0003880003,0.00002053884,0.0001256768,0.001300379,0.0006196597,0.9930236,0.00001368876],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.04287707,0.3317535,0.009371952,0.05861863,0.004170179,0.002900232,0.03275834,0.003415764,0.5141343],"genre_scores_gemma":[0.4899072,0.1363478,0.03957352,0.03949507,0.001829346,0.001915811,0.04233851,0.0006102801,0.2479825],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.03960303,"threshold_uncertainty_score":0.07874501,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03299168729858459,"score_gpt":0.357982561488245,"score_spread":0.3249908741896604,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}